,trastuzumab deruxtecan
astrazeneca,roche,daiichi sankyo
['mbc', 'destiny,breast,03', 'breast', 'destinybreast03']
the #oncoalerttoptweet day 2 #asco22 tweet #destinybreast03 update by : 2l, her 2 mbc, tdxd vs tdm1 - no new safety signals - 7.9% pneumonitis resulted in discontinuation of t-dxd. no gr 4/5 events.
best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??